<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2019-23-3-29-35</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1691</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь показателей аутофагии, апоптоза и внутриклеточной деградации белка с композиционным составом тела у пациентов с хронической болезнью почек, находящихся на программном гемодиализе: результаты когортного исследования</article-title><trans-title-group xml:lang="en"><trans-title>Association of indexes of autophagy, apoptosis and intracellular protein degradation with body composition in chronic kidney disease patients, treated by program dialysis: results of longitudinal prospective study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прометная</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Prometnaya</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Прометная Галина Александровна - врач-нефролог.</p><p>344089, Ростов-на-Дону, ул. 339-Стрелковой Дивизии, д. 14, раб. тел.: 8 (863) 222-03-23, моб. тел.: 8 (918) 558-07-94</p></bio><bio xml:lang="en"><p>Galina A. Prometnaya – MD, nephrologist.</p><p>344089, Rostov-on-Don, ul. 339-Strelkovoi Divizii, 14, Оffice phone: 8 (863) 222-0323, mobile phone: 8 (918) 558-07-94</p></bio><email xlink:type="simple">galusik.ru@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2733-4524</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батюшин</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Batyushin</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Батюшин Михаил Михайлович – профессор, доктор медицинских наук, кафедра внутренних болезней № 2.</p><p>344022, Ростов-на-Дону, пер. Нахичеванский, д. 29, Тел.: +7 918-501-88-01</p></bio><bio xml:lang="en"><p>Mikhail M. Batyushin - MD, PhD, DMedSci, Prof. Internal Medicine Department 2nd.</p><p>344022, Rostov-on-Don, 29 Nakhichevansky Ln, Phone: +7 918-501-88-01</p></bio><email xlink:type="simple">batjushin-m@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бондаренко Николай Борисович - кафедра внутренних болезней № 2, аспирант.</p><p>344022, Ростов-на-Дону, пер. Нахичеванский, д. 29, раб, тел.: 8 (863) 201-44-23; моб. тел.: 8 (950) 851-15-62</p></bio><bio xml:lang="en"><p>Nikolay B. Bondarenko - MD Postgraduate student, Internal Medicine Department 2nd.</p><p>344022, Rostov-on-Don, 29 Nakhichevansky Ln, Phone: 8 (863) 201-44-23; 8 (950) 851-15-62</p></bio><email xlink:type="simple">n.bondarenko61@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Консультативно-диагностическая поликлиника, Государственное бюджетное учреждение Ростовской области Областная детская клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Consultative and diagnostic clinic, State budgetary institution of the Rostov region "Regional Children's Clinical Hospital"</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Ростовский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>22</day><month>03</month><year>2019</year></pub-date><volume>23</volume><issue>3</issue><fpage>29</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Прометная Г.А., Батюшин М.М., Бондаренко Н.Б., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Прометная Г.А., Батюшин М.М., Бондаренко Н.Б.</copyright-holder><copyright-holder xml:lang="en">Prometnaya G.A., Batyushin M.M., Bondarenko N.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1691">https://journal.nephrolog.ru/jour/article/view/1691</self-uri><abstract><sec><title>Цель</title><p>Цель: изучить взаимосвязь активности аутофагии, апоптоза и внутриклеточной деградации белка с композиционным составом тела у пациентов с хронической болезнью почек С5д.</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы. Выполнено когортное проспективное исследование 106 взрослых пациентов с хронической болезнью почек 5 стадии, получающих лечение программным гемодиализом. Изучены данные клинико-анамнестического (жалобы, анамнез), физикального (объективный осмотр) и лабораторного (Beclin-1, 20Б-протеасомы, Bcl-2) обследования. Последнее выполнено на анализаторе «RADIM» (США) с использованием наборов «ELISA» («Cloud-Clone Corp.», США).</p></sec><sec><title>Результаты</title><p>Результаты. У 80 пациентов была определена активность аутофагии (Beclin-1), внутриклеточной деградации белка ^S-протеасома) и апоптоза (Bcl-2), которая классифицирована на кластеры: «высокая активность» Beclin-1 составила 2,4 ± 0,4 нг/мл, «низкая активность» - 1,4 ± 0,2 нг/мл; аналогичных кластеров 20S-протеасомы - 62,0 ± 7,1 и 31,9 ± 6,7 нг/мл; Bcl-2 - 4,2 ± 0,6 и 1,8 ± 0,5 нг/мл соответственно (p&lt;0,05). Низкой активности Beclin-1 и высокой 20S-протеасомы и Bcl-2 соответствовал низкий показатель безжировой массы. Низкой активности Beclin-1 соответствовал низкий показатель общей воды. Низкой активности 20S-протеасомы и Bcl-2 соответствовал высокий показатель общей воды. Низкой активности Beclin-1 соответствовал низкий общий объем жидкости. Низкой активности 20S-протеасомы и Bcl-2 соответствовал высокий общий объем жидкости. Увеличение объема жидкости происходило как за счет внутриклеточной, так и за счет внеклеточной воды.</p></sec><sec><title>Заключение</title><p>Заключение. Больные с ХБП С5д стадии характеризуются снижением активности аутофагии, апоптоза и внутриклеточной деградации белка, обусловленной внутриклеточной энергетической недостаточностью. Влияние аутофагии, апоптоза и деградации белка на показатели безжировой массы, общей воды и общего объема жидкости сопровождается одномоментной активацией одного процесса и торможением другого.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The aim</title><p>The aim: to study the relationship of autophagy activity, apoptosis and intracellular protein degradation with body composition in patients with chronic kidney disease 5d.</p></sec><sec><title>Patients and methods</title><p>Patients and methods. A cohort prospective study was performed on 106 adult patients with chronic kidney disease 5d receiving programmed hemodialysis treatment. The data of clinical and anamnestic</p><p>Original articles Clinical investigations (complaints, anamnesis), physical (objective examination) and laboratory (Beclin-1, 20S proteasome, Bcl-2) examinations were studied. The latter is performed on the “RADIM analyzer” (USA) using the ELISA kits (“Cloud-Clone Corp.”, USA).</p></sec><sec><title>Results</title><p>Results. In 80 patients, the activity of autophagy (Beclin-1), intracellular protein degradation (20S-proteasome) and apoptosis (Bcl-2), which was classified into clusters, was determined: “high activity” Beclin-1 was 2.4 ± 0.4 ng / ml, "low activity" - 1.4 ± 0.2 ng / ml; similar clusters of 20S-proteasomes - 62.0 ± 7.1 ng / ml and 31.9 ± 6.7 ng / ml; Bcl-2 - 4.2 ± 0.6 ng / ml and 1.8 ± 0.5 ng / ml, respectively (p &lt;0.05). The low activity of Beclin-1 and the high 20S proteasome and Bcl-2 corresponded to a low lean mass. The low activity of Beclin-1 corresponded to a low indicator of total water. The low activity of the 20S proteasome and Bcl-2 corresponded to a high total water content. The low activity of Beclin-1 corresponded to a low total fluid volume. The low activity of the 20S proteasome and Bcl-2 corresponded to a high total fluid volume. The increase in fluid volume was due to both intracellular and extracellular water.</p></sec><sec><title>Conclusion</title><p>Conclusion. Patients with CKD 5d stages are characterized by a decrease in the activity of autophagy, apoptosis and intracellular protein degradation due to intracellular energy deficiency. The influence of autophagy, apoptosis and protein degradation on the indicators of lean mass, total water and total fluid volume is accompanied by the simultaneous activation of one process and inhibition of another.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая болезнь почек 5 стадии</kwd><kwd>аутофагия</kwd><kwd>апоптоз</kwd><kwd>внутриклеточная деградация белка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic kidney disease 5 stage</kwd><kwd>autophagy</kwd><kwd>apoptosis</kwd><kwd>intracellular protein degradation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Драчев ИЮ, Шило ВЮ. Хроническая болезнь почек и заместительная почечная терапия: медико-социальные и клинические аспекты проблемы (обзор литературы). Верхневолжский медицинский журнал 2016; 15(4):45-49</mixed-citation><mixed-citation xml:lang="en">Drachev IYU, Shilo VYU. Hronicheskaya bolezn' pochek i zamestitel'naya pochechnaya terapiya: mediko-social'nye i klinicheskie aspekty problemy (obzor literatury). Verhnevolzhskij medicinskij zhurnal 2016; 15(4):45-49</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Feigin VL, Roth GA et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurology 2016;15(9):913-924. Doi: 10.1016/s1474-4422(16)30073-4</mixed-citation><mixed-citation xml:lang="en">Feigin VL, Roth GA et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurology 2016;15(9):913-924. Doi: 10.1016/s1474-4422(16)30073-4</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Золотухин ПВ, Беланова АА, Лебедева ЮА и др. Клеточная физиология повреждения и восстановления почек. Нефрология 2015; 19 (5): 17-22</mixed-citation><mixed-citation xml:lang="en">Zolotuhin PV, Belanova AA, Lebedeva YUA i dr. Kletochnaya fiziologiya povrezhdeniya i vosstanovleniya pochek. Nefrologiya 2015;19(5):17-22</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Пак ЛБ, Дубиков АИ, Кабанцева ТА и др. Апоптоз и патология почек. Нефрология 2013; 17 (4): 36-43 [Pak LB, Dubikov AI, Kabanceva TA i dr. Apoptoz i patologiya pochek. Nefrologiya 2013;17(4):36-43]</mixed-citation><mixed-citation xml:lang="en">Pak LB, Dubikov AI, Kabanceva TA i dr. Apoptoz i patologiya pochek. Nefrologiya 2013;17(4):36-43</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chang IX Kim JN et al. Repression of apurinic/ apyrimidinic endonuclease by p53-dependent apoptosis in hydronephrosis-induced rat kidney. Free Radic Res 2011;45(6):728-734. Doi: 10.3109/10715762.2011.574289</mixed-citation><mixed-citation xml:lang="en">Chang IX Kim JN et al. Repression of apurinic/ apyrimidinic endonuclease by p53-dependent apoptosis in hydronephrosis-induced rat kidney. Free Radic Res 2011;45(6):728-734. Doi: 10.3109/10715762.2011.574289</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fukasawa H, Kaneko M et al. Circulating 20S proteasome is independently associated with abdominal muscle mass in hemodialysis patients. PLoS ONE 2015;10(3):e0121352. Doi: 10.1371/journal.pone.0121352</mixed-citation><mixed-citation xml:lang="en">Fukasawa H, Kaneko M et al. Circulating 20S proteasome is independently associated with abdominal muscle mass in hemodialysis patients. PLoS ONE 2015;10(3):e0121352. Doi: 10.1371/journal.pone.0121352</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt-V: An analysis of error. J Am Soc Nephrol 1993;4:1205-1213</mixed-citation><mixed-citation xml:lang="en">Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt-V: An analysis of error. J Am Soc Nephrol 1993;4:1205-1213</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">National Kidney Foundationio KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015 Nov;66(5):884-930. Doi: 10.1053/j.ajkd.2015.07.015</mixed-citation><mixed-citation xml:lang="en">National Kidney Foundationio KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015 Nov;66(5):884-930. Doi: 10.1053/j.ajkd.2015.07.015</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Levine B, Klionsky DJ. Development by self-digestion: molecular mech- anisms and biological functions of autophagy. Dev Cell 2004; 6(4):463-477</mixed-citation><mixed-citation xml:lang="en">Levine B, Klionsky DJ. Development by self-digestion: molecular mech- anisms and biological functions of autophagy. Dev Cell 2004; 6(4):463-477</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ковалева ОВ, Шитова МС, Зборовская ИБ. Аутофагия: клеточная гибель или способ выживания? Клиническая онкогематология 2014;7(2):103-113</mixed-citation><mixed-citation xml:lang="en">Kovaleva OV, Shitova MS, Zborovskaya IB. Autofagiya: kletochnaya gibel' ili sposob vy-zhivaniya? Klinicheskaya onkogematologiya 2014; 7 (2): 103-113</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumor suppression. Nat Rev Cancer 2009; 9: 563-575</mixed-citation><mixed-citation xml:lang="en">Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumor suppression. Nat Rev Cancer 2009; 9: 563-575</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou F,Yang Y et al. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS Journal 2011; 278(3):403-411. Doi: 10.1111/j.1742-4658.2010.07965.x.</mixed-citation><mixed-citation xml:lang="en">Zhou F,Yang Y et al. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS Journal 2011; 278(3):403-411. Doi: 10.1111/j.1742-4658.2010.07965.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
